Abstract
Until 1980, the effectiveness of long-term treatment with nitrates was taken for granted even though, in the literature, this had never been documented with certainty. With the intention of confirming their effectiveness, Rudolph and his coworkers began performing controlled studies in 1978, the results of which, however, were suggestive of a development of tolerance and rendered questionable the indication for chronic use of nitrates in the treatment of angina pectoris. This conclusion was based on the finding that during long-term treatment neither 20 mg, 40 mg, nor 60 mg isosorbide dinitrate (ISDN) in sustained-release form three times daily led to a decrease in the amount of exercise-induced ST-segment depression, nor did the rate of anginal attacks or nitrate consumption decrease [1] (Fig. 1). In 1980, Parker added to these findings his report on circulatory tolerance associated with a partial loss of antianginal effects of ISDN. He concluded, however, that maintenance of the beneficial effect would require administration of the drug every 2–3 h.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rudolph W, Blasini R, Froer KL, Brügmann U, Mannes A, Hall D (1981) Effects of acute and chronic administration of isosorbide dinitrate, sustained-release form, in patients with angina pectoris. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer Berlin Heidelberg New York, pp 75–81
Schneider W, Maul FD, Bussmann WD, Lang E, Hör G, Kaltenbach M (1988) Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment. Eur Heart J 9: 149–158
Blasini R, Froer KL, Blümel G, Rudolph W (1982) Rapid attenuation of effects of isosorbide dinitrate during long-term treatment of chronic congestive heart failure. Herz 7: 250–258
Parker JO, Farell B, Lahey K, Rose BF (1987) Nitrate tolerance: the lack of effect of N-acetylcysteine. Circulation 76: 572–576
Horowitz JD, Henry CA, Syrjanen ML, Louis WJ, Fish RD, Smith TW, Antman EM (1988) Combined use of nitroglycerin and N-ace-tylcysteine in the management of unstable angina pectoris. Circulation 77: 787–794
Rudolph W, Blasini R, Reiniger R, Brügmann U (1983) Tolerance development during isosorbide dinitrate treatment: can it be circumvented? Z. Kardiol 72[Suppl 3]: 195–198
Rudolph W, Dirschinger J, Reiniger G, Beyerle A, Hall D (1988) When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness? Eur Heart J 9: 63–72
Parker JO, Farell B, Lahey KA (1987) Effect of intervals between doses on development of tolerance to isosorbide dinitrate. N Engl. J Med 316: 1440–1444
Rennhak U, Riebesel T, Biamino G (1985) A double-blind, crossover study on the effectiveness and possible development of tolerance during long-term therapy with isosorbide-5-mononitrate or isosorbide dinitrate slow release in coronary artery disease. In: Cohn JN, Rittinghausen R (eds) Mononitrates. Springer, Berlin Heidelberg New York, pp 147–153
Reiniger G, Kraus F, Dirschinger J, Blasini R, Rudolph W (1985) High-dose transdermal nitroglycerin treatment: attenuated action within 24 hours? Herz 10: 157–162
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schneeweiss, A. (1990). Long-Term Nitrate Therapy — A Decade of Changing Concepts. In: Cardiovascular Drug Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74617-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-74617-8_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50962-2
Online ISBN: 978-3-642-74617-8
eBook Packages: Springer Book Archive